Latest & greatest articles for sepsis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on sepsis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on sepsis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for sepsis

501. Does Resuscitation With Albumin-containing Solutions Improve Mortality in Sepsis?

Does Resuscitation With Albumin-containing Solutions Improve Mortality in Sepsis? SystematicReviewSnapshot TAKE-HOME MESSAGE Albumin use during resuscitation of patients with sepsis may decrease mortality compared with other ?uid solutions. Until additional studies are published, clinicians should consider albumin use an option during the initial resuscitation of patients with sepsis. METHODS DATA SOURCES Electronic searches were con- ducted with MEDLINE, EMBASE, the Cochrane Central Register (...) of Controlled Trials databases (in- ception to April 10, 2010), and the MetaRegister of Controlled Trials, including Medical Editors Trials. Experts in the ?eld were contacted to identify unpublished trials. STUDY SELECTION Randomized controlled trials comparing ?uid resuscitation in sepsis with albumin-containing solutions versus other ?uid resus- citation regimens were selected. Studies that contained a subgroup of sepsis patients within a larger group were also included in the meta-analysis. Inclusion

2011 Annals of Emergency Medicine Systematic Review Snapshots

502. Existing models fail to predict sepsis in an obstetric population with intrauterine infection (PubMed)

Existing models fail to predict sepsis in an obstetric population with intrauterine infection Multiple scoring systems exist to identify inpatients who are at risk for clinical deterioration. None of these systems have been evaluated in an obstetric population. We examined the Systemic Inflammatory Response syndrome (SIRS) and Modified Early Warning score (MEWS) criteria in pregnant women with chorioamnionitis.This was an 18-month retrospective analysis of patients with chorioamnionitis. SIRS (...) and MEWS scores were calculated; clinical outcomes were ascertained, and test characteristics were calculated for the primary outcome of sepsis, intensive care unit transfer, or death.Nine hundred thirteen women with chorioamnionitis were identified. Five women experienced sepsis; there was 1 death. Five hundred seventy-five of the 913 women (63%) met SIRS criteria (95% confidence interval, 59.8-66.2%; positive predictive value, 0.9%). Ninety-two of the 913 women (10.3%) had a MEWS score of ≥ 5 (95

2011 EvidenceUpdates

503. Clinical manifestations but not cytokine profiles differentiate adult-onset Still`s disease and sepsis (PubMed)

Clinical manifestations but not cytokine profiles differentiate adult-onset Still`s disease and sepsis To analyze clinical manifestations, serum ferritin, and serum cytokine levels in patients with adult-onset Still's disease (AOSD) or bacterial sepsis and to evaluate their potential use for differential diagnosis.Twenty-two consecutive patients with the first flare of AOSD and 6 patients with an established diagnosis of AOSD under immunosuppressive therapy were compared with 14 patients (...) with bacterial sepsis. Clinical manifestations were scored in a Pouchot AOSD activity score including elevated serum ferritin levels to obtain a modified Pouchot score. Serum cytokine profiles were analyzed from each patient.The scores of clinical manifestations using a modified Pouchot activity score were significantly higher in patients with active untreated AOSD (mean 5.60 ± 1.93) compared with patients with chronic AOSD (mean 1.16 ± 0.98; p < 0.001) and patients with sepsis (mean 2.38 ± 1.19; p < 0.001

2011 EvidenceUpdates

504. Sepsis toolkit

Sepsis toolkit Clinical Excellence Commission - index | Toggle navigation Search 2019 Patient Experience Symposium 29 & 30 April Download our Quality Improvement Tools Get Involved in Upcoming Events Quality Improvement The CEC’s Quality Improvement Academy aims to enhance leadership and improve frontline capability and capacity in safety and quality. We’re developing a critical mass of clinical leaders and clinical teams to undertake quality improvement. Patient Safety Our initiatives

2011 Clinical Practice Guidelines Portal

505. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. (PubMed)

De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Mortality rates among patients with sepsis, severe sepsis or septic shock ranges from 27% to 54%. Empirical broad-spectrum antimicrobial treatment is aimed at achieving adequate antimicrobial therapy and thus reducing mortality. However, there is a risk that empirical broad-spectrum antimicrobial treatment can expose patients to overuse of antimicrobials. De-escalation has been proposed as a strategy (...) to replace empirical broad-spectrum antimicrobial treatment with a narrower antimicrobial therapy. This is done by either changing the pharmacological agent or discontinuing a pharmacological combination according to the patient's microbial culture results.To evaluate the effectiveness and safety of de-escalation antimicrobial treatment for adult patients diagnosed with sepsis, severe sepsis or septic shock caused by any micro-organism.We searched the Cochrane Central Register of Controlled Trials

2010 Cochrane

506. Long-term cognitive impairment and functional disability among survivors of severe sepsis. (PubMed)

Long-term cognitive impairment and functional disability among survivors of severe sepsis. Cognitive impairment and functional disability are major determinants of caregiving needs and societal health care costs. Although the incidence of severe sepsis is high and increasing, the magnitude of patients' long-term cognitive and functional limitations after sepsis is unknown.To determine the change in cognitive impairment and physical functioning among patients who survive severe sepsis (...) , controlling for their presepsis functioning.A prospective cohort involving 1194 patients with 1520 hospitalizations for severe sepsis drawn from the Health and Retirement Study, a nationally representative survey of US residents (1998-2006). A total of 9223 respondents had a baseline cognitive and functional assessment and had linked Medicare claims; 516 survived severe sepsis and 4517 survived a nonsepsis hospitalization to at least 1 follow-up survey and are included in the analysis.Personal interviews

Full Text available with Trip Pro

2010 JAMA

507. Early versus late pre-intensive care unit admission broad spectrum antibiotics for severe sepsis in adults. (PubMed)

Early versus late pre-intensive care unit admission broad spectrum antibiotics for severe sepsis in adults. Severe sepsis and septic shock have recently emerged as particularly acute and lethal challenges amongst critically ill patients presenting to the emergency department (ED). There are no existing data on the current practices of management of patients with severe sepsis comparing early versus late administration of appropriate broad spectrum antibiotics as part of the early goal-directed (...) therapy that is commenced in the first few hours of presentation.To assess the difference in outcomes with early compared to late administration of antibiotics in patients with severe sepsis in the pre-intensive care unit (ICU) admission period. We defined early as within one hour of presentation to the ED.We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 1, 2009); MEDLINE (1990 to February 2010); EMBASE (1990 to February 2010); and ISI web of Science

Full Text available with Trip Pro

2010 Cochrane

508. A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial (PubMed)

A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial Infections are common complications of neonatal long lines. Heparin has been shown to prolong the effective duration of neonatal long lines and to reduce the ability of bacteria to adhere to foreign surfaces, but the effect of heparin on rates of infection is uncertain.The goal of this study (...) was to evaluate the effect of heparin on the frequency of episodes of catheter-related sepsis (CRS) in infants receiving total parenteral nutrition (TPN) through a neonatal long line.This randomised, controlled, double blind, single-centre clinical trial compared heparin at 0.5 IU/ml with no heparin in TPN infused through a neonatal long line, with episodes of CRS as the primary outcome.210 infants were enrolled (TPN with heparin n=102, TPN without heparin n=108). There was a statistically significant

2010 EvidenceUpdates Controlled trial quality: predicted high

509. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial

Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2010 PedsCCM Evidence-Based Journal Club

510. Long-term mortality and quality of life in sepsis: a systematic review (PubMed)

Long-term mortality and quality of life in sepsis: a systematic review Long-term outcomes from sepsis are poorly understood, and sepsis in patients may have different long-term effects on mortality and quality of life. Long-term outcome studies of other critical illnesses such as acute lung injury have demonstrated incremental health effects that persist after hospital discharge. Whether patients with sepsis have similar long-term mortality and quality-of-life effects is unclear.We performed (...) a systematic review of studies reporting long-term mortality and quality-of-life data (>3 months) in patients with sepsis, severe sepsis, and septic shock using defined search criteria.Systematic review of the literature.None.Patients with sepsis showed ongoing mortality up to 2 yrs and beyond after the standard 28-day inhospital mortality end point. Patients with sepsis also had decrements in quality-of-life measures after hospital discharge. Results were consistent across varying severity of illness

2010 EvidenceUpdates

511. Arterial blood pressure during early sepsis and outcome

Arterial blood pressure during early sepsis and outcome PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2010 PedsCCM Evidence-Based Journal Club

512. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. (PubMed)

Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. Severe sepsis, defined as infection complicated by acute organ dysfunction, occurs more frequently and leads to more deaths in black than in white individuals. The optimal approach to minimize these disparities is unclear.To determine the extent to which higher severe sepsis rates in black than in white patients are due to higher infection rates or to a higher risk of acute organ (...) dysfunction.Analysis of infection-related hospitalizations from the 2005 hospital discharge data of 7 US states and infection-related emergency department visits from the 2003-2007 National Hospital Ambulatory Care Survey.Age- and sex-standardized severe sepsis and infection hospitalization rates and the risk of acute organ dysfunction.Of 8,661,227 non-childbirth-related discharges, 2,261,857 were associated with an infection, and of these, 381,787 (16.8%) had severe sepsis. Black patients had a 67% higher age

Full Text available with Trip Pro

2010 JAMA

513. Early changes in organ function predict eventual survival in severe sepsis

Early changes in organ function predict eventual survival in severe sepsis PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2010 PedsCCM Evidence-Based Journal Club

514. Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study (PubMed)

Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study While outcome continuously improves after liver transplantation, sepsis remains the leading cause of early postoperative mortality. Diagnosis of infections remains particularly difficult in these patients. This study used plasma profiling coupling Proteinchip array with surface-enhanced laser desorption ionization time-of-fly mass spectrometry to search for biomarkers (...) of postoperative sepsis in patients who underwent liver transplantation.Diagnosis of sepsis at day 5 relied on widely accepted clinical signs and positive culture of microbiologic samples. Profiles of day 5 plasma were obtained from SELDI-TOF CM10 chip (BioRad, Marnes-la-Coquette, France) analysis. Mean peak intensity of proteins was compared between septic and nonseptic plasma by U test followed by analysis of the area under the receiver-operating characteristic for the significant peaks. Diagnostic

Full Text available with Trip Pro

2010 EvidenceUpdates

515. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. (PubMed)

Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Lactoferrin, a normal component of human colostrum, milk, tears and saliva can enhance host defence and may be effective in the prevention of sepsis and necrotizing enterocolitis (NEC) in preterm neonates.To assess the safety and effectiveness of oral lactoferrin in the prevention of sepsis and NEC in preterm neonates.The Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library (...) evaluating oral lactoferrin at any dose or duration for the prophylaxis of sepsis or NEC in preterm neonates.Data collection and analysis were performed according to the standard methods of the CNRG.One trial (Manzoni 2008) that randomized 472 very low birth weight infants was eligible. A statistically significant reduction in late-onset sepsis was observed in the groups that received either lactoferrin alone (RR 0.34, 95% CI 0.17, 0.70; RD -0.11, 95% CI -0.18, -0.05; NNT 9, 95% CI 5, 20

2010 Cochrane

516. Outcome of early-onset sepsis in a national cohort of very low birth weight infants (PubMed)

Outcome of early-onset sepsis in a national cohort of very low birth weight infants Early-onset sepsis (EOS) is associated with significant morbidity and mortality among infants with a very low birth weight (VLBW); however, there is a sparse amount of complete data on large cohorts.To evaluate the mortality and major morbidities among VLBW infants with EOS.This was a population-based observational study. Data were prospectively collected by the Israel Neonatal Network on all VLBW infants born

2010 EvidenceUpdates

517. Association between tumor necrosis factor-alpha promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality (PubMed)

Association between tumor necrosis factor-alpha promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality The tumor necrosis factor (TNF)-alpha promoter -308 A/G polymorphism has been reported to be associated with sepsis with inconsistent results. We conducted a systematic review and meta-analysis to determine whether the TNF-alpha -308 A/G polymorphism TNF2 (G/A or A/A) confers susceptibility to sepsis or is associated with increased risk of death from sepsis.We (...) performed an electronic search of OVID MEDLINE from 1950 to June 2008 and EMBASE from 1980 to June 2008.From 1935 reviewed study articles, 25 were included based on predefined inclusion criteria.Two reviewers independently extracted data onto standardized forms.An association between development of sepsis and the TNF2 genotype was found in the overall population (odds ratio, 2.15; 95% confidence interval, 1.45-3.19; p < .01). Stratification by ethnicity indicated that the contribution

2010 EvidenceUpdates

518. Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis (PubMed)

Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis Endotoxin is a potent stimulus of proinflammatory response and systemic coagulation in patients with severe sepsis. Endotoxin is a component of Gram-negative bacteria that triggers an innate immune response through Toll-like receptor 4 signaling pathways in myeloid cells. We evaluated safety and tolerability of two dose regimens of eritoran tetrasodium (E5564), a synthetic Toll-like (...) receptor 4 antagonist, and explored whether it decreases 28-day mortality rate in subjects with severe sepsis.Prospective, randomized, double-blind, placebo-controlled, multicenter, ascending-dose phase II trial.Adult intensive care units in the United States and Canada.Three hundred adults within 12 hrs of recognition of severe sepsis, with Acute Physiology and Chronic Health Evaluation (APACHE) II-predicted risk of mortality between 20% and 80%.Intravenous eritoran tetrasodium (total dose of either

2010 EvidenceUpdates Controlled trial quality: predicted high

519. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis

Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

520. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. (PubMed)

Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. Goal-directed resuscitation for severe sepsis and septic shock has been reported to reduce mortality when applied in the emergency department.To test the hypothesis of noninferiority between lactate clearance and central venous oxygen saturation (ScvO2) as goals of early sepsis resuscitation.Multicenter randomized, noninferiority trial involving patients with severe sepsis

Full Text available with Trip Pro

2010 JAMA Controlled trial quality: predicted high